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Sllmms.ry 
We have previously shown that dendritic ells isolated after overnight culture, which can express 
B7 and are potent stimulators of naive T cell proliferation, are relatively poor at inducing the 
proliferation of a panel of murine T helper 1 (Thl) clones. Maximal stimulation of Thl clones 
was achieved using unseparated splenic antigen presenting cells (APC). An explanation for these 
findings is provided in the present study where we show that FcR + L cells transfected with 
B7 stimulate minimal proliferation of Thl clones in response to anti-CD3 antibodies, incontrast 
to induction of significant proliferation of naive T cells. However, addition of interleukin 12 
(IL-12) to cultures of Thl cells stimulated with anti-CD3 and FcR + B7 transfectants resulted 
in a very pronounced increase in proliferation and interferon 3'(IFN-3") production. Exogenous 
IL-12 did not affect he B7-induced proliferation of naive T cells. This showed that whereas 
costimulatory signals delivered via B7-CD28 interaction are sufficient o induce significant 
proliferation of naive T cells activated through occupancy of the T cell receptor, Thl T cell 
clones require cooperative costimulation by B7 and IL-12. This costimulation was shown to 
be specific by inhibition of proliferation and IFN-y production using chimeric soluble cytolytic 
T lymphocyte-associated antigen 4-human IgG1Fc (CTLA4-Ig) and anti-IL-12 antibodies. 
Furthermore, the significant antigen specific proliferation and IFN-3" production by Thl clones 
observed when splenocytes were used as APC was almost completely abrogated using CTLA4-Ig 
and anti-IL-12 antibodies. Thus two costimulatory signals, B7 and IL-12, account for the ability 
of splenic APC to induce maximal stimulation of Thl clones. IL-10 downregulates the expression 
of IL-12 by IFN-3'-stimulated macrophages and this may account largely for the ability of IL-10 
to inhibit APC function of splenic and macrophage APC for the induction of Thl cell proliferation 
and IFN-3' production. Indeed we show that IL-12 can overcome the inhibitory effect of IL-IO 
for the APC-dependent induction of proliferation and IFN-3" production by Thl clones. These 
results suggest hat proliferation by terminally differentiated Thl clones, in contrast to naive 
T cells, requires timulation via membrane-bound B7 and a cytokine, IL-12. It is possible that 
these signals may result in the activation of unresponsive T cells during an inflammatory response. 
IL-10, by its role in regulating such innate inflammatory esponses, may thus help to maintain 
these T cells in an unresponsive state. 
M ' embrane-bound structures on APCs provide costimula- tory signals for the activation of T cell proliferation 
(1). The most dominant costimulatory interaction described 
to date is that between B7 and CD28 (2-7). CD28 is a homodi- 
meric cell surface protein that is found on the majority of 
T lymphocytes (3, 8, 9). Its ligand, B7/BB1, is a membrane 
glycoprotein that is induced upon activation on B cells, mac- 
rophages (2, 10-13), and activated T cells (14) and is also 
expressed on dendritic ells (15). In conjunction with TCR 
occupancy, the costimulatory signals that are delivered to T 
cells when B7 binds to CD28 result in T cell activation, lym- 
phokine secretion and proliferation (2-7) and are resistant 
to cyclosporin A (16). Moreover, B7/CD28 interaction has 
been shown to prevent he induction of T cell anergy in- 
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duced when T cells are activated by occupancy of the TCR 
in the absence of costimulatory signals (1, 17). Cytolytic T 
lymphocyte-associated antigen 4 (CTLA4) 1 (18), structur- 
ally similar to CD28, is also capable of binding B7 (18, 19) 
and is expressed on activated T lymphocytes. CTLA4 can 
be made into a soluble form by fusing the extracellular do- 
main of CTLA4 to the human IgG1 Fc region (CTLA4-Ig), 
and this molecule inhibits the interaction between B7 and 
CD28/CTLA4 (18). 
In addition to membrane-bound costimulators, it is likely 
that APC-derived cytokines also play a role in T cell activa- 
tion. A prime candidate is IL-12, a heterodimeric cytokine 
comprised of two distinct, but unrelated, gene products. The 
40-kD (p40) and 35-kD (p35) glycosylated protein subunits 
must be assembled for biologically active IL-12 to be secreted 
(20-22). IL-12 is produced by activated macrophages and B 
lymphocytes (23), augments NK and T cell-mediated cyto- 
toxicity, and stimulates IFN-3' production and proliferation 
of NK cells and T cells (20, 24-27), alone or in synergy with 
other factors uch as IL-2 (24). These properties and the ability 
of IL-12 to promote Thl phenotype development in both 
human and mouse T cell populations (28-30) may account 
for the ability of IL-12 to resolve infections with intracel- 
lular bacteria or parasites (31-34). 
CD4 + T cells can be separated both functionally (35) and 
based on the cytokines (36, 37) that they produce in response 
to antigen. Thl cells produce IL-2, IFN-% and lymphotoxin, 
which are responsible for cell-mediated immune responses, 
whereas Th2 cells produce IL-4, IL-5, and IL-10, which pro- 
mote humoral or allergic responses (36, 37). Our previous 
studies (38) suggested that Thl clones were not maximally 
stimulated by dendritic ells isolated after overnight culture, 
which expressed B7 (15) and induced excellent proliferation 
of naive T cells as previously documented (38-42). In con- 
trast, splenic APC induced maximal proliferation and IFN-3~ 
production by Thl clones, whereas these APC were relatively 
poor as compared with dendritic ells at stimulating the in 
vitro proliferation of naive T cells isolated from normal mice 
(38). In this study we show that a panel of Thl clones re- 
quire cooperative interactions between B7/CD28 and IL-12 
for maximal proliferation and IFN-3, production, whereas 
B7/CD28 interaction is sufficient o costimulate he prolifer- 
ation of naive T cells. Furthermore we present evidence that 
these two costimulatory signals, B7 and IL-12, account for 
the ability of splenic APC to induce maximal stimulation 
of Thl cells. 
Materials and Methods 
Animals. Female BALB/cAnN, C57B1/6N normal mice, and 
CB17 scid mice, between 4 and 6 wk of age, were purchased from 
Simonsen Laboratories, Inc. (Gilroy, CA) and used as splenic APC 
donors for the stimulation of antigen-specific Thl clones or as a 
source of macrophages forRT-PCR. 
1 Abbreviations u ed in this paper: CTLA4, cytolytic T lymphocyte-asso- 
ciated antigen 4; RT, reverse transcriptase. 
Culture Medium, Reagents, and Cell Lines. Stimulation a d main- 
tenance ofThl clones was as previously described: HDK1 (BALB/c- 
derived KLH-specific) (43); D1.1 (H-2d-restricted, rabbit Ig- 
specific) (44); H66-61 (BALB/c-derived, autoreactive) (45); 1.31 
(C57B1/6-derived, Ovalbumin-spedfic) (G. Terres, unpublished ob- 
servations). Clones were expanded and maintained in RPMI 1640 
(JR Scientific Inc., Woodland, CA) containing 10% FCS (JR 
Scientific Inc.), r-glutamine (2 mM), penicillin (100 U/ml), strep- 
tomycin (100 #g/ml), hepes buffer (10 mM), sodium pyruvate (1 
raM), 2-mercaptoethanol (0.05 raM; Sigma Chemical Co., St. Louis, 
MO), and cRPMI, supplemented with mouse recombinant (r)IL-2 
(330 U/ml). In some cases clones were stored in liquid nitrogen 
and cells were thawed and maintained in murine rib2, as above, 
5-7 d before assay. L cells were transfected with the FcR (CD32) 
plus and minus human B7 (46) and maintained in DMEM sup- 
plemented asfor cRPMI but in the absence ofIL-2. The untrans- 
fected L cells did not express detectable levels of B7 as determined 
by failure to react with CTLA4-Ig fusion protein or anti-mouse 
B7 mAb (data not shown). Spleen cell suspensions from BALB/c 
and C57B1/6 mice were treated with 0.83% ammonium chloride 
to lyse red blood cells, washed, and resuspended in cRPMI. 
Cytokines, mAbs, andlmmunoassays. Mouse riD12 was obtained 
by transfecting COS 7 cells with the cDNAs encoding the p35 
and p40 subunits of IL-12, which were obtained by PCR cloning 
using sequences described by Schoenhaut et al. (47). Anti-ILl2 an- 
tibodies, C15.1.2 and C15.6.7 are described by Wysocka, M., and 
G. Trinchieri (unpublished observations). GLl13 used as an iso- 
type matched control for anti-ILl2, was provided by Dr. J. Abrams 
(DNAX Research Institute). CTLA-4-Ig was kindly provided by 
Dr. Peter Lane (Basel Institute for Immunology, Basel, Switzer- 
land) (18, 48). An isotype matched control, human IgG1 was 
provided by PharMingen (San Diego, CA). Biotinylated anti-mouse 
CD8cr B220, anti-lA d, anti-mouse Mel-14 FITC (leukocyte c ll 
adhesion molecule [LECAM]), anti-mouse CD4, and anti-mouse 
CD3-e were obtained from PharMingen. 
IFN-y was detected in the supernatants from cell cultures using 
a two-site sandwich ELISA (49), and the sensitivity was 150 pg/ml. 
Proliferation of Thl clones was measured by incorporation of
[3H]thymidine (1 /~Ci/well, specific activity, 2 Ci/mMol; New 
England Nuclear, Boston, MA), added to cultures after superna- 
tants were removed for cytokine determination. Plates were pulsed 
for 8-12 h and then processed for scintillation counting. 
Stimulation of Naive T Cells and ThI Clones. CD4 + T cells 
were enriched by negative selection using a Magnetic Activated 
Cell Sorter as previously described (MACS; Biotec GMBH; Miltenyi, 
Germany) (50), and then further purified to homogeneity using 
a FACStar Pl~s| flow cytometer (Becton Dickinson & Co., Moun- 
tain View, CA) to achieve 99.8% CD4 § T cells. At this stage 
Mel-14 d~ cells were also removed by sorting to remove previously 
activated or memory T cells (51). T cell clones (2 x 104/well) 
were stimulated with the appropriate antigen and MHC matched 
splenic APC (4 x 10S/well) (3,000 fads), or with soluble anti- 
CD3 (50-2,000 ng/ml) and L cells transfected with CD32 plus 
or minus human B7 (250-4,000 cells/well) (7,000 fads). Cells were 
incubated in96-well flat bottomed plates at 37~ in a humidified 
incubator (5% CO2). Cultures were in the presence orabsence of
any of the following either alone or in combination: IL-12 (50-75 
U/ml) (mock control Cos supernatant, ot shown, had no effect 
at 1 in 80 dilution and greater, at which concentration the Cos 
IL-12 was used); IL-IO (100 U/ml); anti-IL-12 mAhs (100 #g/ml) 
or an isotype matched control GLl13 mAb (100 #g/ml); CTLA4- 
Ig (10 #g/ml) or a human IgG1 control (10/~g/ml). 100 #1 of su- 
pernatant was removed at60 h and assayed for IFN-3~ production. 
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Proliferation was measured by adding [3H]thymidine to the re- 
maining culture and incubating for an additional 8-12 h. 
RNA-PCR. RNA was prepared using a modification of the 
guanidinium isothiocyanate (GuSCN)/cesium chloride method (52) 
from CB17 scid peritoneal cells (106 cellsAample) stimulated over- 
night with IFN-7 (100 U/ml), IFN-7 (100 U/ml) and IL-10 (100 
U/ml), or no stimulation. Reverse transcription (RT) and PCR 
were performed for p40 and p35 IL-12 mRNA expression, using 
the RT-Semi-quantitative PCR method previously described (53). 
IL-12 sequences u ed were: P35 (1I,-12) Sense 5'-GAG GAC TTG 
AAG ATG TAC CAG-3', Size (325) Antisense 5'-TTC TAT CTG 
TGT GAG GAG GGC-Y, Probe 5'-AAG CTC TGC ATC CTG 
CTT CAC GCC TTC-Y; P40 (IL-12) Sense 5'-GAC CCT GCC 
CAT TGA ACT GGC-3', (Size 415) Antisense 5'-CAA CGT TGC 
ATC CTA GGA TCG-3', Probe 5'-TGT CTG CGT GCA AGC 
TCA GGA-Y. 
Results and Discussion 
Cooperative Effects of B7 and IL-12 on IFN- 7 Production and 
Proliferation of Thl Clones. We have previously shown that 
a panel of Thl clones, in contrast to naive T cells, responded 
poorly to antigen presented by dendritic ell APCs isolated 
after overnight culture in contrast to splenic APCs (38). The 
relatively poor capacity of these dendritic ells isolated after 
overnight culture to stimulate Thl clones was surprising since 
these cells expressed B7, a dominant costimulator for T cell 
proliferation, possibly as a result of some activation during 
isolation. To dissect further the requirements for optimal Thl 
proliferation and IFN- 7 production, as compared with naive 
T cells, soluble anti-CD3 antibody and stable FcP,-bearing 
L cell transfectants expressing high levels of B7, or parental 
FcR + L cells without B7, were used to stimulate a panel 
of Thl clones or naive CD4 + T cells. (The subline of L cells 
used in these studies does not express murine B7 as deter- 
mined by their failure to stain with CTLA4-Ig or anti-mouse 
B7.) B7 transfectants resulted in significant costimulation for 
anti-CD3-induced proliferation of naive CD4 + T cells, but 
minimal proliferation of Thl clones (Fig. 1 A). FcR + L cells 
lacking B7 gave no proliferation of Thl clones or naive 
CD4 + T cells stimulated with soluble anti-CD3. Moreover, 
addition of IL-12 gave no proliferation of naive CD4 + T 
cells and minimal to no proliferation when Thl cells were 
stimulated with parental FcR-bearing L cells and anti-CD3. 
By contrast, avery significant cooperative effect on prolifera- 
tion of all the Thl clones was observed when IL-12 was added 
to the B7 transfectants, whereas IL-12 did not increase the 
proliferation of naive CD4 + T cells costimulated with B7 
transfectants. In contrast to the lack of effect of IL-12 on naive 
CD4 + T cell proliferation, cooperation between B7 and 
IL-12 for stimulation of IFN-7 production by both Thl dones 
and naive CD4 + T cells was observed (Fig. 1 B). Inter- 
mediary levels of IFN-7 were induced in the Thl clones with 
either B7 transfectants or IL-12 alone in contrast to the min- 
imal proliferation. The cooperative ffect of B7 and IL-12 
for Thl proliferation was IL-2 dependent (data not shown). 
This was shown by inhibition with anti-IL-2 and anti-IL-2 
receptor mAbs. 
To ensure that the effects of B7 or IL-12 on Thl or naive 
CD4 + T cell proliferation and IFN- 7 production were spe- 
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cific, CTLA4-Ig and anti-IL-12 antibodies were included in 
the stimulation cultures. CTLA4-Ig almost completely in- 
hibited the proliferation of naive CD4 + T cells (Fig. 2 A) 
induced by FcR + B7 transfectants and anti-CD3, and to a 
lesser extent he proliferation of Thl clones (Fig. 2 A). The 
effect of CTLA4-Ig on IFN-7 production by Thl clones was 
minimal, perhaps reflecting that IFN-7 is often inducible in 
the absence of B7 (Fig. 2 B). The cooperative effect of IL-12 
and B7 on Thl proliferation was partially blocked by CTLA4- 
Ig, more so by anti-IL-12 alone, and essentially completely 
with a combination of both reagents, confirming specificity 
of the interactions (Fig. 2 B). Anti-IL-12 had no effect on 
the proliferation of naive CD4 + T cells stimulated with 
anti-CD3 and B7 transfectants. The low levels of IFN-7 pro- 
duced by CD4 + T cells, stimulated with anti-CD3 together 
with B7 and IL-12 were abolished by inclusion of CTLA4- 
Ig or anti-IL-12 mAbs (Fig. 2 B). 
In summary, interaction of B7 and CD28 is sufficient o 
induce maximal proliferation of naive CD4 + T cells stimu- 
lated by anti-CD3, and in no circumstances can this stimula- 
tion be enhanced by addition of IL-12. In contrast, costimu- 
lation with B7 of Thl clones timulated by anti-CD3 induced 
minimal proliferation and this was significantly enhanced by 
addition of IL-12. Although IL-12 did not show any effect 
on the anti-CD3-induced proliferation of CD4 + T cells, it 
cooperated with B7 to induce very low levels of IFN-7 (Fig, 
1 B). IL-12 or B7 alone induced minimal levels of IFN-7 
production from anti-CD3 stimulated CD4 + T cells. It is 
possible that the IFN-'y is being produced by a small number 
of contaminating memory or preactivated T cells, although 
measures were taken to avoid this by FACS | sorting Mel- 
14 bright cells (51). 
Splenic APC-induced Thl Proliferation and 1FN-T Produc- 
tion Are Inhibited by CTLA4-Ig and Anti-IL-12 Antibodies. To 
determine whether the Thl cell proliferation and IFN-3' 
production induced when splenocytes were used as APC in- 
volved B7 or IL-12, CTLA4-Ig and anti-IL-12 antibodies were 
included in cultures of Thl clones stimulated with specific 
antigen presented by splenic APCs. Again, proliferation of 
Thl clones was partially blocked by CTLA4-Ig, to a greater 
extent by anti-IL-12 antibodies, and was almost completely 
abrogated by addition of the two reagents (Fig. 3 A). A similar 
trend was observed for the inhibition of IFN-7 production 
by Thl clones (Fig. 3 B), although still to a slightly lesser 
extent han the effects of CTLA4-Ig and anti-IL-12 antibodies 
on proliferation (Fig. 3 A). This confirmed the physiological 
relevance of our findings in the anti-CD3 system demon- 
strating an important role for B7 together with IL-12 in in- 
ducing optimal proliferation in an antigen-specific system. 
These results may have important implications for the regu- 
lation of the immune response and induction of anergy (1). 
Thl clones may represent terminally differentiated T ceils that 
produce lower amounts of IL-2 upon stimulation with an- 
tigen but high levels of effector cytokines uch as IFN-7, 
in contrast o naive T ceils that produce high levels of IL-2 
and only low levels of other cytokines uch as IL-3, IFN-'y, 
and GM-CSF (54). Since B7 alone is not sufficient o activate 
a high level of proliferation in terminally differentiated Thl 
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Figure 1. Cooperative effects of 
1I.-12 and B7 on proliferation and 
IFN3, production by a panel of Thl 
clones and naive CD4 + T cells. L 
cells transfected with CD32 (FcR) 
plus or minus B7 were titrated in 
96-well plates and Thl clones (tint 
four panels) or naive CD4 + T cells 
(last panel) were added (2 x 104/ 
well) with soluble anti-CD3 in the 
presence or absence of IL-12 (50-75 
U/ml), for 48-60 h. (A) Prolifera- 
tion of Thl clones and naive 
CD4 + T cells was measured by 
[3H]thymidine incorporation. (B) 
IFN3" production by Thl clones and 
naive CD4 + T cells was measured 
in supernatants removed at 60 h. 
The data are shown as the mean of 
triplicate cultures _+ SD. 
clones, IL-12 may play an important role in determining the 
responsiveness of such T cells. Since IL-12 is produced by 
macrophages after stimulation with bacterial or other intra- 
cellular pathogens (23, 28), it is possible that innate inflam- 
matory immune responses may lead to stimulation of T cells, 
which otherwise appear unresponsive. The interaction orB7 
with CD28 expressed on Th2 clones was shown to result 
in increased proliferation and cytokine production (data not 
shown), supporting the recently published studies of McAr- 
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thur and Raulet (55). However, in contrast to its effects on 
Thl clones, IL-12 showed no costimulatory effect for prolifer- 
ation and cytokine production by Th2 clones (data not shown), 
supporting a recently published study (56). 
IL-I2 Overcomes the Inhibitory Effect of lL-lO on Splenic APC 
Function for Induction of Proliferation and IFN-'T Production by 
Thl Clones. We (57) and others (58, 59) have shown that 
IL-10 inhibits Thl IFN-3' production and proliferation by 
inhibiting splenic and macrophage APC function. In addi- 
Figure 2. Effect ofanti-IL-12 and 
CLTA4-Ig on B7 and Ib12 stimu- 
lation of Thl or naive CD4 + T cell 
proliferation and IFN-3, production. 
L cells transfected with CD32 (FcR) 
and B7 were titrated in 96-well 
plates (single point shown) and Thl 
clones or naive CD4 + T cells were 
added (2 • 104/well) with soluble 
anti-CD3 (50-2,000 ng/ml) in the 
presence or absence of II.,12 (50-75 
U/ml), anti-IL-12 (100 /zg/ml), 
GLl13 (100 /zg/ml), and/or 
CTLA4-Ig (10/zg/ml) singly or in 
combination, as indicated. Thl 
clones plus or minus CD32 + L 
cells plus anti-CD3 gave, alone 100 
-900 c.p.m, or plus II.-12, 800- 
4,500 c.p.m., and 50-100 ng/ml 
tFN-3,, and without anti-CD3 gave 
<500 c.p.m, and 2-20 IFN-y 
ng/ml. Naive CD4 + T cells alone, 
with no accessory cells gave 46 
c.p.m, and undetectable IFN-"/with 
anti-CD3, and 59 c.p.m, and undetectable IFN-3', with anti-CD3 plus IL-12. (.4) Proliferation of Thl clones and naive CD4 + T cells was measured 
by [3H]thymidine incorporation. (B) IFN-y production by Thl clones and naive CD4 + T cells was measured in supernatants removed at 60 h. The 
data are shown as the mean of triplicate cultures + SD. 
tion, IL-10 inhibits macrophage induced Thl development 
which is mediated by IL-12 (50, 60). These observations and 
the present findings that B7 and IL-12 cooperate for Thl 
proliferation and IFN-'y production i duced by splenic APCs 
prompted us to test whether IL-10's regulatory effects resulted 
from downregulation f IL-12. Fig. 4, A and B demonstrate 
that IL-10 inhibited Thl clone proliferation and IFN-3' produc- 
tion when splenocytes were used as APCs as we have previ- 
ously shown (57, 61). Addition of IL-12 to these cultures 
completely restored proliferation by IL-10-inhibited Thl 
clones. The ability of IL-12 to overcome the inhibition of 
IFN-31 production by IL-10 was often not complete. This 
could reflect a need for other costimulators for induction of 
IFN-y production that are also inhibited by IL-10. Possible 
candidate molecules are, B7, whose xpression has been shown 
to be downregulated by IL-10 on murine macrophages (62) 
and human monocytes (62a). Moreover, Kubin et al., in a 
parallel study (62a) show that IL-12 synergizes with B7/CD28 
interaction i  inducing efficient proliferation and cytokine 
production by activated human T cells. However, since IL- 
12 can completely overcome the inhibition of Thl cell prolifer- 
ation, but not IFN-~/production, by IL-10, it is likely that 
other factors, whose induction by macrophages (61) andmono- 
cytes (63) is also inhibited by IL-10, may be required for op- 
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Figure 3. Anti-IL-12 and CTLA4- 
Ig specifically block splenic APC 
function for induction of prolifera- 
tion and IFN-'y production by Thl 
clones. Spleen APCs were titrated 
(single point shown) in 96-well 
plates and Thl clones were added 
(2 x 104) with specific antigen and 
stimulated in the presence of I1:12 
(50-75 U/ml), anti-I~12 (100 
p.g/ml) and/or CTLA4-Ig (10/xg/ml) 
singly or in combination asindicated. 
(A) Proliferation of Thl clones was 
measured by [3H]thymidine incor- 
poration. (B) IFN-3' production by 
Thl clones was measured in super- 
natants removed at 60 h as described 
in Materials and Methods. The data 
are shown as the mean of triplicate 
cultures _+ SD. 
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Figure 4. II.,12 overcomes the inhibitory effect of IL-10 on splenic APC function for induction of proliferation and IFN-7 production by Thl clones. 
Spleen APCs were titrated (single point shown) in 96-well plates and Thl clones were added with specific antigen in the presence or absence of 1I:12 
(50-75 U/ml), IL-10 (100 U/ml), or I1:12 and IL-IO together. (A) Proliferation of Thl clones was measured by [3H]thymidine incorporation. (B) IFN-y 
production by Thl clones was measured in supernatants removed at 60 h. The data are shown as the mean of triplicate cultures _+SD. 
Figure 5. I1:10 downregulates 
p35 and i>40 11:12 mR.NA expres- 
sion in IFN-?-stimuhted peritoneal 
macrophages. Scid peritoneal cells 
(106/well) were used as a source of 
enriched macrophages and in- 
cubated in RPMI as described in 
Materials and Methods with IFN-y 
(100 U/ml) in the presence or ab- 
sence IL-10 (100 U/ml), or medium 
alone and incubated for 12 h at 37~ 
in a humidified incubator (5% 
CO2). RT-PCR was performed 
as previously described (49). (A) 
mRNA (starting from ,'~4,000 cell equivalents) levels w r  a sessed for hypoxanthine ribosyl transferase expression to ensure that all samples had similar 
input RNA. Samples were diluted (as indicated) so that message levels fell within the linear part of the standard curve. (/3) mRNA expression of 
p35 IL-12 (dilutions ofcDNA were made starting from ~,,25,000 cell equivalents). (C) mRNA expression of p40 I1:12 (dilutions of cDNA were made 
starting from ,x,25,000 cell equivalents). For a uniform level of HPRT expression equivalent in all three duplicate samples the arbitrary units (a.u.) 
of expression for I1:12 were: Macrophages (i) + medium only, p35 = 45 a.u; p40 = 79 a.u.: (ii) + IFN-% p35 = 39 a.u; p40 = 158 a.u.: (iii) 
+ IFN- 7 + IL-10, p35 = 7 a.u; p40 = 27 a.u, 
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ritual IFN-3' production by Thl cells. Indeed, D'Andrea et 
al. (64), have shown that TNF-ot and IL-1 are required in 
addition to IL-12 to overcome the inhibitory effects of IL-10 
on IFN-y production by human NK cells. In addition, we 
have recently shown that these costimulators are required for 
maximal IFN-qr production by committed Thl TCK- 
transgenic CD4 + T cells, although IL-12 has a dominant 
effect (Macatonia, S. E., C.-S. Hsieh, M. Wysocka, G. Trin- 
chieri, K. M. Murphy, and A. O'Garra, manuscript submitted 
for publication). Furthermore, IL-12 could also enhance 
proliferation to a small extent and IFN-3' to a larger extent, 
by Thl clones stimulated with splenic APCs and antigen. 
IL-IO Inhibits IFN-y-induced Macrophage Expression of lL- 
12. To confirm that IL-10 was inhibiting APC function by 
downregulating the expression of IL-12, we analyzed expres- 
sion of mRNA encoding P40 and P35 IL-12 in enriched popu- 
lations of macrophages from the peritoneal cavity of scid mice 
after stimulation in the presence and absence of IL-10. IFN-3' 
was shown to upregulate xpression of both P35 and p40 
IL-12 mKNA, although the effect on p40 expression was 
more marked (Fig. 5). IFN-3,-induced expression of p35 and 
p40 IL-12 mKNA by macrophages was completely abrogated 
by the addition of IL-10, bringing the levels to below those 
observed in the absence of stimulation. These results uggest 
that IL-10 may not only inhibit Thl development from naive 
T cells by inhibiting IL-12 production (28, 29), but in addi- 
tion downregulates the costimulatory activity of IL-12 on 
already differentiated Thl cells for induction of effector func- 
tion and proliferation. 
In summary, B7 and IL-12 cooperate for maximal induc- 
tion of proliferation and IFN-~/production by terminally 
differentiated Thl clones, which are poorly stimulated by ei- 
ther signal alone. These results suggest hat IL-12 together 
with B7 may play a role in activating unresponsive or anergic 
T cells. That together these two costimulatory signals play 
an important role in T cell activation is supported by similar 
findings using human T cells (62a). B7 is expressed on den- 
dritic cells and can be upregulated on macrophages by con- 
comitant signals that upregulate IL-12. Thus insult with in- 
fectious agents may lead to inflammatory esponses that could 
influence otherwise unresponsive T ceils, and IL-10 by its 
role in regulating such innate inflammatory responses (31, 
32, 61, 63, 64, 65) may thus help to maintain these T cells 
in an unresponsive state. 
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